DekaBank Deutsche Girozentrale
CLLS

DekaBank Deutsche Girozentrale’s Cellectis CLLS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,000
Closed -$86K – 1433
2021
Q3 		$86K Hold
7,000
– – ﹤0.01% 1309
2021
Q2 		$108K Hold
7,000
– – ﹤0.01% 1319
2021
Q1 		$130K Hold
7,000
– – ﹤0.01% 1254
2020
Q4 		$203K Buy
+7,000
New +$157K ﹤0.01% 1180

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

DekaBank Deutsche Girozentrale's CLLS Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 7,000 shares — an estimated $86K sold.

DekaBank Deutsche Girozentrale first reported a position in CLLS in Q4 2020 and held it in 4 quarters. The position peaked at $203K in Q4 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 7,000 Cellectis shares in Q4 2021, an estimated $86K.
  • DekaBank Deutsche Girozentrale first reported a position in Cellectis in Q4 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Cellectis position peaked at $203K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.